The synergistic effect of the two agonists plus the T/P therapy proved effective: eight out of nine of the mice saw tumor ...

Fully enrolled the Phase 2/3 trial of lead asset CTX-009 (DLL4 and VEGF-A bispecific antibody) in patients with biliary tract cancers (BTC); top-line data readout is on track for the end of the first ...

ST. LOUIS — All morning, nurses had been coming in, taking vitals, offering blankets, pressing buttons to silence alarms. It ...

On slide 15, I’ll begin by reviewing the FDA approved indications for GAVRETO, which include the treatment of adult patients ...

Medically reviewed by Femi Aremu, PharmD Borage is an herb from the Borago officinalis plant, which grows across the Middle ...

TNF = tumor necrosis factor. Immunoglobulin allotypes may also be involved in the development of diffuse interstitial lung disease. [33] CFA is characterized by inflammation, damage, and ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

Other causes of lung cancer are well known, like radon gas exposure, which happens to be fairly prevalent in Appalachia. It’s ...

Dr. Watanabe and his team from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

Medically reviewed by Susan Russell, MDLung cancer prognosis tends to be better for people diagnosed in earlier stages of the ...

NKTR-255 in combination with durvalumab following chemoradiation was well-tolerated in patients with non–small cell lung ...